Philips and Leading Network of Healthcare Centers and Clinics in Russia to Modernize the Country's Regional Healthcare Infrastructures

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) today announced the signing of a 10-year strategic partnership agreement with the Expert Group of Companies, one of Russia's leading network of healthcare centers and clinics, to jointly improve the efficiency of the delivery of patient care in Russia. As part of the multi-year agreement, which has a total value of approximately EUR 74 million, Philips will equip the Group's new clinics with healthcare solutions for high-quality diagnosis and treatment.

Innovative MRI and CT scanners, advanced ultrasound and angiography systems combined with integrated clinical informatics solutions will optimize clinical processes, improve workflows and reduce costs. As the technology partner, Philips will also provide its deep clinical expertise, consulting services and technology planning for multidisciplinary medical centers and specialized cardiac centers. Furthermore, Philips and the Expert Group of Companies have plans to develop joint educational initiatives in the areas of MRI, ultrasound and endovascular diagnostics.

"The strategic partnership agreement with Philips, a global leader in health technology, will make innovative solutions for diagnosis and treatment available to more patients in Russia," said Elena Latysheva, President of the Expert Group of Companies. "The Expert Group of Companies has ten years of experience in the medical industry in Russia. The integrated approach and advanced technologies for diagnostics and treatment that will be available in our centers will improve the standards of medical care. We are confident that the partnership with Philips will help us achieve our strategic goal to become one of the largest private healthcare networks in Russia by 2026."

"This long-term cooperation with the Expert Group of Companies furthers our mission to improve people's lives across the health continuum - from healthy lifestyle, disease prevention and early diagnosis to treatment and home care," said Arman Voskerchyan, CEO of Philips Russia and Central Asia. "We firmly believe that this cooperation will improve patient outcomes and help to develop high-tech medical care in Russia."

The partnership will aim to improve the provision of medical services in existing Expert diagnostic centers across the country as well as establishing new hospitals and developing new business models. The Expert Group of companies also considers joining public-private partnerships in the field of public health. It represents a new format of cooperation, bringing together consultancy for business development and providing innovative medical equipment for clinics. The Expert Group of Companies and Philips plan to jointly develop a long-term strategy and transformation program for existing Expert centers. Moreover, the companies will focus on the development of a regional network of 35 multidisciplinary medical centers to expand the range and scope of service provision.

Cardiovascular disease is one of the major challenges for Russia's healthcare system. The collaboration aims to develop and implement integrated programs for cardiology ranging from prevention and diagnosis, to treatment and home care. The partners will address doctors' training and the introduction of new therapy methods into clinical practice.

The Expert Group of Companies aims to focus on the development of cooperation models between governmental and private medical institutions in the field of endovascular diagnostics and treatment across Russia. Pilot public-private partnership projects will be implemented in the Russian regions of Lipetsk, Voronezh and Yaroslavl, which are collectively home to more than five million people.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The Company leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the Company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. The Company's health technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 70,000 employees with sales and services in more than 100 countries.

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...